To assess the role of NAT10 in pancreatic cancer, cell lines with high NAT10 expression (PANC-1 and AsPC-1) and low NAT10 expression (CFPAC-1 and MIA PaCa-2) were selected. Here, NAT10 is linked to familial pancreatic carcinoma.